A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus

Influenza A virus infection is usually associated with acute lung injury, which is typically characterized by tracheal mucosal barrier damage and an interleukin 17A (IL-17A)-mediated inflammatory response in lung tissues. Although targeting IL-17A has been proven to be beneficial for attenuating inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lei, Shi, Chenchen, Zeng, Xian, Cen, Lifeng, Mei, Xiaobin, Fan, Jiajun, Ju, Dianwen, Zhu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421727/
https://www.ncbi.nlm.nih.gov/pubmed/34504501
http://dx.doi.org/10.3389/fimmu.2021.727941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421727/
https://www.ncbi.nlm.nih.gov/pubmed/34504501
http://dx.doi.org/10.3389/fimmu.2021.727941

Ejemplares similares